PURR Share Price Performance
US$3.23
-0.67 (-17.18%)
Price US$3.23
Share Pricen/a
No recently updated narratives available.
Hyperliquid Strategies Inc., through its subsidiary, operates as a a biotechnology company that owns a platform for biologic medicines of single or bifunctional action. The company was incorporated in 2025 and is based in New York, New York.